Breaking News
Is Too Late to Establish a Department of Peace?
Making Corporatism Great Again
Could Trump End Up Triggering The Globalist "Great Reset"?
SUDDEN DROP II : The Great Arizona Haboob of 2025
Top Tech News
Neuroscientists just found a hidden protein switch in your brain that reverses aging and memory loss
NVIDIA just announced the T5000 robot brain microprocessor that can power TERMINATORS
Two-story family home was 3D-printed in just 18 hours
This Hypersonic Space Plane Will Fly From London to N.Y.C. in an Hour
Magnetic Fields Reshape the Movement of Sound Waves in a Stunning Discovery
There are studies that have shown that there is a peptide that can completely regenerate nerves
HERE COMES THE MOTHERSHIP
Swedish startup unveils Starlink alternative - that Musk can't switch off
Video Games At 30,000 Feet? Starlink's Airline Rollout Is Making It Reality
Grok 4 Vending Machine Win, Stealth Grok 4 coding Leading to Possible AGI with Grok 5
Longeveron developing stem cell treatments for Frailty, Alzheimers and other aging diseases
Longeveron is a privately funded startup. The Longeveron-grown Mesenchymal Stem Cells (LMSCs) are multipotent stem cells.
Mesenchymal stem cells, or MSCs, are multipotent stromal cells that can differentiate into a variety of cell types, including: osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue). MSC have been found in organisms (in-vivo) and have been studied as well in tissue culture (in-vitro).
Nextbigfuture interviewed Dr. Joshua Hare, Longeveron Chief Science Officer. Dr. Joshua Hare co-founded Longeveron in 2014 utilizing intellectual property and technology exclusively licensed from the University of Miami, where he is also the founding Director of the university's Interdisciplinary Stem Cell Institute (ISCI).